Since CD151 can favor EMT in HCC cells via the PI3K/Akt signaling pathway, Zhang et al. also considered the activation of this pathway relating to sorafenib resistance of HCC cells (61). The gene discussed is CD151; the disease is hepatocellular carcinoma.